The use of guanfacine was also associated with a decrease in GFAP‐positive cells in the prefrontal lobe and cingulate gyrus, just as activation of microglial cells in the spinal cord after peripheral nerve injury may make pain persist. The gene discussed is GFAP; the disease is peripheral nerve injury.